← Back to Search

Point-of-Sale Poster Strategies for Reducing Teen Tobacco Use

N/A
Recruiting
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation
Awards & highlights

Study Summary

This trial is researching ways to reduce teen tobacco use, such as changing the number and type of posters at point-of-sale sites. It'll look at cigarettes, e-cigs, smokeless tobacco, and little cigars/cigarillos.

Who is the study for?
This trial is for college students aged 18-20 who haven't been in a previous StoreLab study. It's not suitable for those with medical or psychiatric conditions that could interfere with following the study rules.Check my eligibility
What is being tested?
The study tests how different numbers and types of tobacco product posters at points-of-sale influence young adults' tobacco use. It looks at cigarettes, e-cigarettes, smokeless tobacco, and cigarillos across two concurrent studies.See study design
What are the potential side effects?
Since this trial involves exposure to advertising rather than a physical intervention, traditional side effects are not applicable. However, it may impact participants' attitudes or behaviors regarding tobacco use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation
This trial's timeline: 3 weeks for screening, Varies for treatment, and there is one visit in this research: this variable is assessed at that visit, immediately after the experimental manipulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-reported cigarette smoking risk after shopping in the StoreLab
Alcohol or Other Drugs use
Self-reported smokeless tobacco use risk
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Reduced PosterExperimental Treatment1 Intervention
This condition will allow for a reduced number of posters with pricing information to be displayed.
Group II: No priceExperimental Treatment1 Intervention
This condition will allow for many posters with no pricing information to be displayed.
Group III: Status QuoActive Control1 Intervention
This condition will allow for many posters with pricing information to be displayed.

Find a Location

Who is running the clinical trial?

RANDLead Sponsor
139 Previous Clinical Trials
614,364 Total Patients Enrolled
2 Trials studying Tobacco Use
542 Patients Enrolled for Tobacco Use

Media Library

Reduced Poster Clinical Trial Eligibility Overview. Trial Name: NCT05604508 — N/A
Tobacco Use Research Study Groups: Status Quo, Reduced Poster, No price
Tobacco Use Clinical Trial 2023: Reduced Poster Highlights & Side Effects. Trial Name: NCT05604508 — N/A
Reduced Poster 2023 Treatment Timeline for Medical Study. Trial Name: NCT05604508 — N/A
~140 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top